Stock Scorecard
Stock Summary for Opko Health Inc (OPK) - $1.62 as of 10/28/2026 8:39:06 PM EST
Total Score
10 out of 30
Safety Score
24 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for OPK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OPK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OPK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for OPK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for OPK (24 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 2 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 2 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for OPK
Financial Details for OPK
Company Overview |
|
|---|---|
| Ticker | OPK |
| Company Name | Opko Health Inc |
| Country | USA |
| Description | OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 11/4/2026 |
Stock Price History |
|
| Last Day Price | 1.62 |
| Price 4 Years Ago | 1.25 |
| Last Day Price Updated | 10/28/2026 8:39:06 PM EST |
| Last Day Volume | 2,536,332 |
| Average Daily Volume | 4,340,866 |
| 52-Week High | 1.77 |
| 52-Week Low | 0.98 |
| Last Price to 52 Week Low | 65.31% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 53.90 |
| Sector PE | 48.27 |
| 5-Year Average PE | -10.47 |
| Free Cash Flow Ratio | 4.05 |
| Industry Free Cash Flow Ratio | 97.36 |
| Sector Free Cash Flow Ratio | 37.95 |
| Current Ratio Most Recent Quarter | 3.35 |
| Total Cash Per Share | 0.40 |
| Book Value Per Share Most Recent Quarter | 1.59 |
| Price to Book Ratio | 1.02 |
| Industry Price to Book Ratio | 202.97 |
| Sector Price to Book Ratio | 32.63 |
| Price to Sales Ratio Twelve Trailing Months | 2.07 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.90 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.96 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 746,328,000 |
| Market Capitalization | 1,209,051,360 |
| Institutional Ownership | 27.56% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.93% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -12.60% |
| Annual Earnings Growth | -324.02% |
| Reported EPS 12 Trailing Months | -0.09 |
| Reported EPS Past Year | -0.08 |
| Reported EPS Prior Year | -0.18 |
| Net Income Twelve Trailing Months | -72,890,000 |
| Net Income Past Year | -225,680,000 |
| Net Income Prior Year | -53,224,000 |
| Quarterly Revenue Growth YOY | 4.30% |
| 5-Year Revenue Growth | -15.82% |
| Operating Margin Twelve Trailing Months | -15.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 300,761,000 |
| Total Cash Past Year | 369,074,000 |
| Total Cash Prior Year | 431,936,000 |
| Net Cash Position Most Recent Quarter | -37,732,000 |
| Net Cash Position Past Year | 35,359,000 |
| Long Term Debt Past Year | 333,715,000 |
| Long Term Debt Prior Year | 422,184,000 |
| Total Debt Most Recent Quarter | 338,493,000 |
| Equity to Debt Ratio Past Year | 0.79 |
| Equity to Debt Ratio Most Recent Quarter | 0.78 |
| Total Stockholder Equity Past Year | 1,267,959,000 |
| Total Stockholder Equity Prior Year | 1,365,448,000 |
| Total Stockholder Equity Most Recent Quarter | 1,184,166,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -134,016,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.18 |
| Free Cash Flow Past Year | -190,820,000 |
| Free Cash Flow Prior Year | -208,499,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.50 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/27/2026 6:18:22 AM EST |